3D Systems Corp (DDD) 30.47 $DDD 3D Systems: Pay More

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
3D Systems Corp (DDD) 30.47 $DDD

3D Systems: Pay More Attention To This Rather Than Earnings
Stone Fox Capital - at Seeking Alpha - Fri Feb 27, 2:35PM CST

DDD: 30.47 (+0.41), HPQ: 34.84 (+0.83)

3D Systems Needs To Do Better
Bill Maurer - at Seeking Alpha - Fri Feb 27, 2:30PM CST

DDD: 30.47 (+0.41)

Autodesk: Healthy Q4, FY16 Guidance Offers Upside
AtonRa Partners - at Seeking Alpha - Fri Feb 27, 10:43AM CST

DDD: 30.47 (+0.41), ADSK: 64.24 (+3.23)

Lessons From A Dozen Years Of Short Selling
Whitney Tilson - Seeking Alpha - Fri Feb 27, 9:39AM CST
(Editor's Note: Long-time contributor Whitney Tilson developed a presentation titled "Lessons from a Dozen Years of Short Selling" that he's presented at a handful of investment conferences in New York City. With his permission, we're now...
MBI: 9.00 (-0.04), FCEL: 1.31 (+0.06), HLF: 31.01 (-3.81), AFC: 25.59 (+0.14), VJET: 8.91 (+0.05), LL: 51.86 (+2.63), BLDP: 2.29 (-0.07), NSR: 26.52 (-0.14), TXTR: 28.21 (-0.48), RPTP: 9.27 (-0.37), LNKD: 267.20 (-3.56), ONVO: 5.92 (-0.14), XONE: 15.13 (-0.40), ARNA: 4.51 (-0.24), AGM: 31.94 (+0.35), PLUG: 3.08 (-0.03), FB: 78.97 (-1.44), DDD: 30.47 (+0.41), DECK: 74.24 (+0.50), TRIP: 89.25 (-0.61), CSLT: 7.29 (-0.21), LRN: 16.93 (unch), PCLN: 1,237.48 (-3.77), NFLX: 474.91 (-8.12), CROX: 11.15 (+0.46), CALL: 7.72 (+0.18), WRLD: 82.11 (-1.09), SODA: 17.92 (+0.66)

3D Systems Misses on Q4 Earnings, Revenues Lag (Revised) - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 27, 8:00AM CST
3D Systems (DDD) reported disappointing fourth-quarter and full-year 2014 results, continuing its recent trend of missing estimates. Adjusted earnings for the quarter came in at 13 cents per share, lagging the Zacks Consensus Estimate of 20 cents.
DDD: 30.47 (+0.41), FORM: 9.82 (-0.08), CRUS: 30.11 (-0.12), EXAR: 10.72 (-0.06)

3D Systems expects sales hike
at Investor's Business Daily - Thu Feb 26, 5:32PM CST
The 3D printing system maker said Q4 EPS minus 1-time items rose 10.5% to 21 cents, missing by 3 cents amid higher spending to support expansion. Revenue grew 21% to $187.4 mil, below the consensus of $202 mil, and the 4th straight quarter of...
DDD: 30.47 (+0.41)

3D Systems' (DDD) CEO Avi Reichental on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 26, 2:10PM CST

DDD: 30.47 (+0.41)

3D Systems' Shares, Post-Earnings, Still Look Too Risky
at The Street - Thu Feb 26, 1:25PM CST
Hewlett-Packard's possible entry into 3-D printing looms as a threat.
DDD: 30.47 (+0.41), SSYS: 62.06 (+0.61), HPQ: 34.84 (+0.83)

3D Systems: No Goodwill Impairment Despite Weak Results
Illuminati Investments - at Seeking Alpha - Thu Feb 26, 11:59AM CST

DDD: 30.47 (+0.41)

3D Systems Corporation Earnings: Mediocre With Negative Undertones
Steve Heller, The Motley Fool - Motley Fool - Thu Feb 26, 11:26AM CST
3D Systems reported record fourth-quarter and full-year 2014 earnings results before the market opened on Thursday. For the quarter, 3D Systems grew revenue by 21% year over year to $187.4 million, translating to $0.01 in earnings per share, and...
DDD: 30.47 (+0.41)

3D Systems (DDD) Stock Is Up Today After Earnings Report
at The Street - Thu Feb 26, 11:15AM CST
3D Systems (DDD) is gaining Thursday after guiding in line with analysts' estimates for full year 2015.
DDD: 30.47 (+0.41)

3D Systems Shows Signs Of Rebound With 2015 Forecast
at Investor's Business Daily - Thu Feb 26, 10:36AM CST
Product delays and acquisition costs continue to pressure 3D Systems (DDD), which reported fourth-quarter earnings Thursday morning that fell short of expectations but gave more positive 2015 guidance. The 3D printer maker's earning minus items rose...
VJET: 8.91 (+0.05), DDD: 30.47 (+0.41), XONE: 15.13 (-0.40), SSYS: 62.06 (+0.61)

3D Systems: The Fight For Survival Begins
AtonRa Partners - at Seeking Alpha - Thu Feb 26, 9:23AM CST

DDD: 30.47 (+0.41)

3D Systems higher on in-line guidance, spending caution
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 8:51AM CST

DDD: 30.47 (+0.41), XONE: 15.13 (-0.40)

3D Systems (DDD) Beats Q4 Earnings Estimates, Misses Revenues - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 26, 8:20AM CST
3D Systems (DDD) Beats Q4 Earnings Estimates, Misses Revenues
DDD: 30.47 (+0.41)

Stock Futures Rise as Inflation Falls 0.7%, Durable Goods Rebound
at The Street - Thu Feb 26, 7:43AM CST
Core U.S. consumer inflation comes in higher than estimates and durable goods in January recover from December's lull.
KSS: 73.80 (+2.11), DDD: 30.47 (+0.41), SHLD: 37.60 (+1.55), CRM: 69.38 (-0.86)

3D Systems misses by $0.04, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 7:02AM CST

DDD: 30.47 (+0.41)

Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Feb 25, 4:30PM CST

KSS: 73.80 (+2.11), HSNI: 67.57 (+2.63), LKQ: 24.58 (-0.20), ACIW: 19.85 (-0.04), CNP: 20.79 (-0.23), OGE: 32.51 (-0.22), GCAP: 9.49 (+0.28), MRGE: 4.00 (+0.05), CYBX: 68.50 (+1.90), KOP: 16.12 (-2.36), IRDM: 9.58 (-0.27), AES: 12.97 (+0.34), ONE: 3.30 (-0.11), FIG: 8.04 (-0.07), ITC: 38.73 (+0.30), MITL: 10.16 (+0.57), MBLY: 35.48 (-0.31), MDXG: 10.35 (-0.13), AMWD: 52.66 (+3.60), MGLN: 64.07 (+1.17), EXH: 32.47 (-1.25), FRO: 2.51 (-0.27), NXTM: 17.18 (-0.93), SEAS: 18.74 (-0.43), DDD: 30.47 (+0.41), AKRX: 53.81 (+0.34), EXLP: 23.42 (+0.58), CWEI: 49.06 (-3.73), HSC: 16.49 (-0.22), IQNT: 14.75 (+0.20), ARCC: 17.30 (+0.05), SNAK: 10.09 (+0.07), HEES: 24.48 (-2.42), SDRL: 11.53 (+0.07), NTLS: 4.52 (-0.30), NXST: 54.53 (-0.49), SHLD: 37.60 (+1.55), CCG: 7.79 (+0.10), ICON: 33.77 (-0.41), FCH: 10.77 (+0.12), HAWK: 37.04 (+1.17), EME: 44.03 (+0.51), CHS: 18.23 (+0.42), BUD: 126.66 (-0.83), LTM: 57.80 (-1.11), AMCX: 72.02 (-0.91), CNSL: 21.28 (-0.56), LPI: 11.93 (-0.33), GOGO: 17.98 (-0.22), SFY: 3.13 (+0.06), ANSS: 85.97 (+0.38), BDBD: 10.31 (+0.18), BIN: 27.99 (+0.16), CRI: 88.77 (+1.46), RHP: 60.10 (+0.86), ACTA: 16.76 (+0.29)

Salesforce.com Soars After Hours; Avago Also Up
at Investor's Business Daily - Wed Feb 25, 3:55PM CST
Stocks struggled for direction, ending narrowly mixed Wednesday amid better-than-expected new-home sales and a second day of testimony from Fed chief Janet Yellen. But some stocks made waves after hours. Salesforce.com (CRM) bolted 11% in extended...
KSS: 73.80 (+2.11), GRUB: 42.01 (+0.26), DDD: 30.47 (+0.41), ARUN: 24.81 (+2.20), HPQ: 34.84 (+0.83), ELX: 7.95 (+0.02), ICON: 33.77 (-0.41), AL: 38.24 (-0.83), SPLK: 67.25 (-2.32), MELI: 130.97 (-0.04), ROST: 105.81 (+6.76), AVGO: 127.62 (-1.63), CRM: 69.38 (-0.86)

Anatomy Of Market Tops
Sean Emory - Seeking Alpha - Wed Feb 25, 1:58PM CST
Overview: Trying to determine a market top is perhaps one of the more difficult and costly undertakings in investing. The problem resides in human behavior and the belief that each market peak may be the last market peak. This feeling continues...
EWG: 29.70 (+0.12), SPY: 210.66 (-0.72), IBM: 161.94 (+1.07), DDD: 30.47 (+0.41)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Beverly Hills MD's Dermal Cream Wins Key Beauty Award

Updated Category News Views 2

A Surprise Win in the Beauty World Who doesn't love an underdog story, right? Beverly Hills MD has slid into the limelight with their Dermal Repair Complex snagging the award for 'Beauty Product of the Year.' Talk about sending shockwaves through the beauty industry! Now, these guys might not be a household name yet, but you better believe they've got everyone's attention...

Continue Reading
Curaleaf Expands in Florida Amid Rising Cannabis Demand

Updated Category News Views 1

Curaleaf's Bold Moves in Florida's Ganja Gold Rush Fresh out of the gate, Curaleaf is saddling up for a wild ride into Florida's cannabis frontier. They've just thrown open the doors of their latest dispensary in Riverview, cranking their statewide count up to 77. Now, isn’t that something? If you're tracking these folks, you know that bringing their nationwide total to...

Continue Reading
AI Platform Suno Sued for Exploiting Artists' Identities

Updated Category News Views 1

AI and the Music Business: A Legal Storm Brews Well, it looks like the music world’s hitting a rough patch with AI in the crosshairs. We've got Korein Tillery, a heavyweight in the legal arena, throwing down the gauntlet against Suno, an AI music-generation platform. Folks, welcome to the battleground where art meets tech and identity theft takes a whole new meaning....

Continue Reading
Rackspace Lawsuit Deadline: Investors Must Take Action

Updated Category News Views 2

Rackspace's Legal Predicament: Time for Action Alright folks, if you're holding shares of Rackspace Technology (NASDAQ:RXT), it’s time to sit up and pay attention. This is about more than bad PR or a temporary hiccup in the stock price—this is serious business. We’ve got until September 28, 2026, to decide if we’re in or out on this class action lawsuit train....

Continue Reading
Clinical Trials Services Market Set for Big Growth

Updated Category News Views 0

Eyeing a Market Surge in Clinical Trials Numbers don't lie, and they're painting a promising picture for the clinical trials services market with a solid 8% growth forecasted annually till 2031. From a modest $66.20 billion in 2026, we're looking at ballooning to a hefty $97.41 billion by 2031. What’s cooking? Let me dish it out for you. Key Drivers and Dynamics North...

Continue Reading
Art and Science Blend in Dr. De La Cruz's Approach

Updated Category News Views 2

Redefining Aesthetic Surgery: An Artistic Approach The world of plastic surgery is often seen through the lens of beauty and symmetry, but for Dr. Emmanuel De La Cruz, it's like staring into a whole different universe. This Houston-based plastic surgeon isn't just removing fat—he's reshaping the human canvas with the eye of a sculptor. Beyond the Standard Cut and Snip...

Continue Reading
IVD Study Success: Hybrid Monitoring Boosts Oversight

Updated Category News Views 1

New Strategies for IVD Clinical Studies It's high time we addressed the tangled web of managing in vitro diagnostic (IVD) clinical studies. We're talking about walking a tightrope where sponsors have to juggle regulatory scrutiny, data integrity, and operational efficiency—all while pushing innovation. Simply put, the old ways of doing things just aren't cutting it...

Continue Reading
CAPR Faces Lawsuit and FDA Delay: Investor Alert

Updated Category News Views 1

Trouble Brewin' for Capricor Investors Buckle up, folks. Capricor Therapeutics (NASDAQ: CAPR) is caught in a storm, facing not just the lengthy arm of law with a securities class action, but also a seemingly endless wait with the FDA's decision on their lead product. We're talking serious implications for anyone with skin in the game. The FDA's Delayed Blessing So the...

Continue Reading
Orbis Celebrates 20 Years of Eye Care in Macau

Updated Category News Views 2

Celebrating Two Decades of Eye Health Innovation Orbis, a name synonymous with eye care worldwide, has hit a remarkable milestone. Celebrating two decades of commitment to eye health in Macau, they've rolled out their Flying Eye Hospital with a mission of profound impact. This isn't just about a fancy airplane; it’s about real, lasting change through training projects...

Continue Reading
Faruqi & Faruqi Urge Wix Investors to Act Now

Updated Category News Views 3

Ticking Clock for Wix Investors' Legal Moves The buzz in the stock market is louder than a bull on Wall Street, especially if you're tangled up with Wix.com Ltd. (NASDAQ: WIX). We've got Faruqi & Faruqi, LLP laying down serious advice: move fast or maybe lose your spot in line. The deadline to noodle over your position as a lead plaintiff in their federal securities class...

Continue Reading

Top 5 Most Recently Viewed Articles

Executive Shifts at Title Resources Group: Key Leadership Updates

Updated Category News Views 233

Leadership Changes at Title Resources Group Title Resources Group (TRG), a leading title insurance underwriter, is undergoing an important executive transition. Kevin Wall is set to be appointed as the new Chief Executive Officer (CEO), succeeding J. Scott McCall, who will transition to the role of Vice Chairman of the Board of Directors. This strategic move, reflecting...

Continue Reading
Bear Stewart Recall: Soy Allergy Alert Shakes Confidence

Updated Category News Views 56

Undeclared Ingredients: Not Just Another Casual Glitch Well, here we go again. Bear Stewart LLC's latest revelation sends alarm bells ringing for anyone with a nose for allergic disorders. Their Bakr Brown Butter Chocolate Chunk Ready To Bake Cookie Dough found its way to store shelves with an ingredient that can cause mayhem for many – soy. Imagine thinking you’re...

Continue Reading
Exploring the Impact of Inclusivity in Global Advertising

Updated Category News Views 134

The Importance of Inclusive Advertising In today's dynamic advertising landscape, inclusivity plays a critical role in how brands connect with their audiences. Inclusivity isn't just a buzzword; it's becoming essential for brands aiming to resonate with diverse demographics, reflecting the world we live in. XR Extreme Reach, a leading global technology company, has taken...

Continue Reading
Suburban Propane Partners with Local Organizations for Community Support

Updated Category News Views 117

Suburban Propane's Commitment to Community Well-being Suburban Propane Partners, L.P. (NYSE: SPH), a leading provider of propane and renewable energy solutions, is dedicated to making a positive impact in local communities. Recently, they partnered with Sharing House, a community organization focused on assisting those in need. This collaboration aimed to gather essential...

Continue Reading
GoHealth Inc. Achieves New Heights with Stock Performance

Updated Category News Views 227

GoHealth's Significant Stock Surge Recently, GoHealth Inc. (GOCO) has made headlines as it reached a remarkable milestone by hitting a 52-week high of $14.94. This achievement illustrates a substantial 12% gain over the past week and a phenomenal 40% surge over the last six months. Investors and market analysts have been captivated by these developments, considering the...

Continue Reading